Every material Form 8-K TRIMAS CORP has filed with the SEC since April 30, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
TriMas reported third-quarter 2026 net sales of $178.7 million, up 7.7% from a year earlier, and GAAP income from continuing operations of $13.5 million, compared with a loss in the prior-year quarter. The company reaffirmed its full-year 2026 adjusted EPS outlook of $1.60 to $1.70 and raised its sales growth outlook to 4% to 6%, while Specialty Products' operating margin declined and it agreed to sell the Rapak business.
Net sales were $178.7 million, up 7.7% from $166.0 million; GAAP diluted EPS from continuing operations was $0.37, compared with a loss of $0.12.
Adjusted diluted EPS from continuing operations was $0.50, up from $0.17, which the company attributed mainly to interest income, cost reductions and a lower share count.
2026 adjusted diluted EPS outlook was reaffirmed at $1.60 to $1.70; the sales growth outlook was raised to 4% to 6% from 3% to 6%.
Repurchased 233,150 shares for $9.3 million in the third quarter; $67.3 million remains under the authorization. Cash and cash equivalents were $1,158.5 million at September 30, 2026.
TriMas reported second quarter 2026 net sales of $174.6 million, up 1.6% from a year earlier, and adjusted diluted EPS from continuing operations of $0.52, up from $0.20. The company raised the low end and midpoint of its full-year 2026 adjusted diluted EPS outlook to $1.60 to $1.70, from $1.50 to $1.70. GAAP diluted EPS of $1.86 includes a $53.9 million non-cash deferred tax impact tied to the TriMas Aerospace divestiture.
Q2 2026 net sales $174.6 million, up 1.6%; adjusted operating profit $14.9 million, up 29.1%
Full-year 2026 adjusted diluted EPS outlook now $1.60 to $1.70, versus $1.50 to $1.70 previously
Repurchased 509,264 shares for $18.9 million in Q2; $76.5 million remained under the authorization at June 30, 2026
Cash and cash equivalents of $1.24 billion at June 30, 2026; Q2 free cash flow use of $12.9 million
TriMas reported first quarter 2026 net sales of $168.3 million, up 10.4%, and a loss from continuing operations of $51.8 million, or $1.38 per diluted share, versus income of $1.9 million a year earlier. The loss was driven mainly by a $53.9 million non-cash tax impact tied to the March 16, 2026 sale of TriMas Aerospace, while adjusted diluted EPS from continuing operations rose to $0.24 from $0.15. The company reaffirmed its 2026 sales and margin outlook and issued full-year adjusted diluted EPS guidance of $1.50 to $1.70.
Net sales were $168.3 million, up 10.4% from $152.5 million, with organic growth of 7.3%.
GAAP loss from continuing operations was $51.8 million, or $1.38 per diluted share, including a $53.9 million non-cash tax impact from the TriMas Aerospace divestiture.
Adjusted diluted EPS from continuing operations was $0.24, compared with $0.15 in the prior year period.
Full-year 2026 adjusted diluted EPS guidance is $1.50 to $1.70; sales growth of 3% to 6% was reaffirmed.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every TRIMAS CORP filing is on SEC EDGAR ↗. 8-K briefs of other companies →